Literature DB >> 6646121

Isolation and characterization of an interferon-resistant cell line deficient in the induction of (2'-5')oligoadenylate synthetase activity.

S Salzberg, D H Wreschner, F Oberman, A Panet, M Bakhanashvili.   

Abstract

To screen for cells with different sensitivities to interferon (IFN), NIH 3T3 mouse fibroblasts were subcloned and examined for their response to IFN treatment. Of 30 clones tested, 2 appeared to be relatively resistant to IFN, since the replication of both vesicular stomatitis virus and mengovirus was not inhibited, even in the presence of 1,000 U of IFN per ml. One resistant (A10) and one sensitive (A5) clone were further analyzed. In both clones, murine leukemia virus replication was equally inhibited by IFN, indicating the presence of functional receptors for IFN in the resistant clone. Using the (2'-5')oligoadenylate (2-5A) radiobinding assay, we could demonstrate that both clones contained the RNase L protein. Furthermore, this enzyme appears to be active, since a similar reduction in the rate of protein synthesis was evident after the introduction of exogenous 2-5A to the cells. We also analyzed the activity of another enzyme in the 2-5A pathway, namely, 2-5A synthetase. In the sensitive cells (A5), the induction of enzyme activity was proportional to the IFN concentration used, reaching a maximum of more than a 10-fold increase over the background of untreated cells. However, little if any induction over the basal activity was observed in the resistant cells (A10) when similar doses of IFN were used. It is thus probable that the lack of induction of 2-5A synthetase activity by IFN in A10 cells is at least partly responsible for their relative resistance to IFN treatment.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6646121      PMCID: PMC370037          DOI: 10.1128/mcb.3.10.1759-1765.1983

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  26 in total

1.  Increased nuclease activity in cells treated with pppA2'p5'A2'p5' A.

Authors:  A G Hovanessian; J Wood; E Meurs; L Montagnier
Journal:  Proc Natl Acad Sci U S A       Date:  1979-07       Impact factor: 11.205

2.  Synthesis and breakdown of pppA2'p5'A2'p5'A and transient inhibiton of protein synthesis in extracts from interferon-treated and control cells.

Authors:  B R Williams; I M Kerr; C S Gilbert; C N White; L A Ball
Journal:  Eur J Biochem       Date:  1978-12

3.  pppA2'p5'A2'p5'A: an inhibitor of protein synthesis synthesized with an enzyme fraction from interferon-treated cells.

Authors:  I M Kerr; R E Brown
Journal:  Proc Natl Acad Sci U S A       Date:  1978-01       Impact factor: 11.205

Review 4.  Antitumor effects of interferon.

Authors:  I Gresser; M G Tovey
Journal:  Biochim Biophys Acta       Date:  1978-10-27

5.  Interferon-induced enzymatic activities and their role in the antriviral state.

Authors:  C Baglioni
Journal:  Cell       Date:  1979-06       Impact factor: 41.582

6.  Interferon and cell division. IX. Interferon-resistant L1210 cells: characteristics and origin.

Authors:  I Gresser; M T Bandu; D Brouty-Boyé
Journal:  J Natl Cancer Inst       Date:  1974-02       Impact factor: 13.506

7.  Interferon, double-stranded RNA and RNA degradation. Fractionation of the endonucleaseINT system into two macromolecular components; role of a small molecule in nuclease activation.

Authors:  L Ratner; R C Wiegand; P J Farrell; G C Sen; B Cabrer; P Lengyel
Journal:  Biochem Biophys Res Commun       Date:  1978-04-14       Impact factor: 3.575

8.  Rapid quantitation of interferon with chronically oncornavirus-producing cells.

Authors:  M Aboud; O Weiss; S Salzberg
Journal:  Infect Immun       Date:  1976-06       Impact factor: 3.441

9.  Anticellular and antiviral effects of pppA(2'p5'A)n.

Authors:  A G Hovanessian; J N Wood
Journal:  Virology       Date:  1980-02       Impact factor: 3.616

10.  Inhibition of cell-free protein synthesis by pppA2'p5'A2'p5'A: a novel oligonucleotide synthesized by interferon-treated L cell extracts.

Authors:  M J Clemens; B R Williams
Journal:  Cell       Date:  1978-03       Impact factor: 41.582

View more
  8 in total

1.  Loss of (2'-5')oligoadenylate synthetase activity by production of antisense RNA results in lack of protection by interferon from viral infections.

Authors:  A De Benedetti; B A Pytel; C Baglioni
Journal:  Proc Natl Acad Sci U S A       Date:  1987-02       Impact factor: 11.205

2.  Clonal derivatives of the RD-114 cell line differ in their antiviral and gene-inducing responses to interferons.

Authors:  R Kumar; R K Tiwari; J Kusari; G C Sen
Journal:  J Virol       Date:  1987-09       Impact factor: 5.103

3.  2'-5'-oligoadenylate synthetase gene expression in normal and murine sarcoma virus-transformed NIH 3T3 cells.

Authors:  S David; A Nissim; J Chebath; S Salzberg
Journal:  J Virol       Date:  1989-03       Impact factor: 5.103

4.  Studies on the role of the 2'-5'-oligoadenylate synthetase-RNase L pathway in beta interferon-mediated inhibition of encephalomyocarditis virus replication.

Authors:  R Kumar; D Choubey; P Lengyel; G C Sen
Journal:  J Virol       Date:  1988-09       Impact factor: 5.103

Review 5.  Apoptosis and cell growth inhibition as antitumor effector functions of interferons.

Authors:  H Strander
Journal:  Med Oncol       Date:  2001       Impact factor: 3.064

6.  Type I and type II interferons inhibit the translation of murine norovirus proteins.

Authors:  Harish Changotra; Yali Jia; Tara N Moore; Guangliang Liu; Shannon M Kahan; Stanislav V Sosnovtsev; Stephanie M Karst
Journal:  J Virol       Date:  2009-03-18       Impact factor: 5.103

7.  Structure of two forms of the interferon-induced (2'-5') oligo A synthetase of human cells based on cDNAs and gene sequences.

Authors:  P Benech; Y Mory; M Revel; J Chebath
Journal:  EMBO J       Date:  1985-09       Impact factor: 11.598

8.  Interferon-alpha resistance in renal carcinoma cells is associated with defective induction of signal transducer and activator of transcription 1 which can be restored by a supernatant of phorbol 12-myristate 13-acetate stimulated peripheral blood mononuclear cells.

Authors:  A Brinckmann; S Axer; D Jakschies; I Dallmann; J Grosse; T Patzelt; T Bernier; A Emmendoerffer; J Atzpodien
Journal:  Br J Cancer       Date:  2002-02-01       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.